MAPT and Alzheimer disease: AD mouse models often present transgenic tau overexpression that leads to a forceful, extreme inflammation, artificially altering experimental processes and results, compared to the milder inflammatory response by microglia that is more likely to occur in the brain, especially in the early stage of disease [54,55,56].